跳至主要内容
临床试验/NCT02110979
NCT02110979已完成不适用

Validation of a Patient Decision Aid for Type 2 Diabetes

EPI-Q4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
4
主要终点
Knowledge score

研究概览

简要总结

The objectives of this study are to compare measurements in knowledge of decision options, support for decision making, uncertainly in decision making, and clarity of values important to decision making among two groups of type 2 diabetes patients, those who receive a Patient Decision Aid and those who receive usual care.

详细描述

This study uses a randomized, controlled trial design to compare knowledge of decision options, support for decision making, uncertainly in decision making, and clarity of values important to decision making among patients with uncontrolled type 2 diabetes who are only taking metformin medication. The intervention is a Patient Decision Aid (PDA) video delivered via the internet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes
  • Age 18 or older
  • English speaking
  • Currently taking metformin
  • Inadequate glycemic control in the opinion of the investigator
  • Is considering additional medication options on the advice of their physician
  • Can provide a valid email address
  • Access to the internet and able to read and respond to internet questionnaires

排除标准

  • Participation in a clinical trial of a diabetes medication within 1 year
  • Currently taking more than two (2) medications for diabetes
  • Has been exposed to diabetes medications from more than three (3) drug classes
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women

结局指标

主要结局

Knowledge score

时间窗: 6 weeks

The primary endpoint for this investigation is the knowledge total score at final followup 4- 6 weeks after randomization between the PDA versus usual care groups. Questions are about available treatments and specific to the information on medication options available to people with type 2 diabetes when metformin alone does not achieve adequate glycemic control.

次要结局

  • Decisional conflict(6 weeks)

研究者

发起方
EPI-Q
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alicia Shillington

Executive Vice President

EPI-Q

研究点 (4)

Loading locations...

相似试验